Syquant Capital Sas has filed its 13F form on July 18, 2025 for Q2 2025 where it was disclosed a total value porftolio of $302 Million distributed in 14 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Blueprint Medicines Corp with a value of $103M, Kellogg CO with a value of $90.9M, Enstar Group LTD with a value of $24.2M, Walgreens Boots Alliance, Inc. with a value of $14.7M, and Triumph Group Inc with a value of $14.6M.

Examining the 13F form we can see an increase of $45.7M in the current position value, from $256M to 302M.

Below you can find more details about Syquant Capital Sas portfolio as well as his latest detailed transactions.

Portfolio value $302 Million
Healthcare: $130 Million
Consumer Defensive: $90.9 Million
Financial Services: $35.5 Million
Industrials: $14.6 Million
Technology: $14.6 Million
Consumer Cyclical: $11.6 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 14
  • Current Value $302 Million
  • Prior Value $256 Million
  • Filing
  • Period Q2 2025
  • Filing Date July 18, 2025
  • Form Type 13F-HR/A
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Syquant Capital Sas Portfolio

Follow Syquant Capital Sas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syquant Capital Sas, based on Form 13F filings with the SEC.

News

Stay updated on Syquant Capital Sas with notifications on news.